Have a personal or library account? Click to login
Neonatal alloimmune thrombocytopenia due to anti-HPA-5b (Bra) Cover

Neonatal alloimmune thrombocytopenia due to anti-HPA-5b (Bra)

Paid access
|Oct 2020

Abstract

Neonatal alloimmune thrombocytopenia (NAIT) results from maternal immunization against fetal platelet antigens and can occur during the first pregnancy. The most common complications of NAIT are neonatal thrombocytopenia, intracerebral hemorrhage, and fetal death. Most cases of NAIT in Causasians are caused by anti-HPA-1a (PlA1). Anti-HPA-5b (Bra) accounts for only 4.3 percent of all NAIT cases. NAIT due to anti-HPA-5b is thought to be milder and have fewer complications than NAIT caused by anti-HPA-1a because of the lower number of HPA-5b antigenic sites per platelet. This report describes a severe case of NAIT due to anti-HPA-5b that was treated by intrauterine platelet transfusion.

DOI: https://doi.org/10.21307/immunohematology-2019-493 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 127 - 131
Published on: Oct 14, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 S.A. Campbell-Lee, D. Desantis-Parsons, R. Sue Shirey, T.S. Kickler, published by American National Red Cross
This work is licensed under the Creative Commons License.